- Home
- BCLI vs RVSN Comparison
BCLI vs RVSN Comparison
Compare BCLI & RVSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCLI
- RVSN
- Stock Information
- Founded
- BCLI 2000
- RVSN 2016
- Country
- BCLI United States
- RVSN Israel
- Employees
- BCLI N/A
- RVSN N/A
- Industry
- BCLI Biotechnology: Biological Products (No Diagnostic Substances)
- RVSN
- Sector
- BCLI Health Care
- RVSN
- Exchange
- BCLI Nasdaq
- RVSN Nasdaq
- Market Cap
- BCLI 6.4M
- RVSN 6.6M
- IPO Year
- BCLI N/A
- RVSN 2022
- Fundamental
- Price
- BCLI $0.92
- RVSN $0.44
- Analyst Decision
- BCLI Strong Buy
- RVSN
- Analyst Count
- BCLI 1
- RVSN 0
- Target Price
- BCLI $30.00
- RVSN N/A
- AVG Volume (30 Days)
- BCLI 366.6K
- RVSN 1.1M
- Earning Date
- BCLI 05-13-2025
- RVSN 05-06-2025
- Dividend Yield
- BCLI N/A
- RVSN N/A
- EPS Growth
- BCLI N/A
- RVSN N/A
- EPS
- BCLI N/A
- RVSN N/A
- Revenue
- BCLI N/A
- RVSN $1,300,000.00
- Revenue This Year
- BCLI N/A
- RVSN $1,861.54
- Revenue Next Year
- BCLI N/A
- RVSN N/A
- P/E Ratio
- BCLI N/A
- RVSN N/A
- Revenue Growth
- BCLI N/A
- RVSN 815.49
- 52 Week Low
- BCLI $0.72
- RVSN $0.27
- 52 Week High
- BCLI $10.05
- RVSN $2.72
- Technical
- Relative Strength Index (RSI)
- BCLI 35.85
- RVSN 53.37
- Support Level
- BCLI $1.12
- RVSN $0.36
- Resistance Level
- BCLI $0.82
- RVSN $0.43
- Average True Range (ATR)
- BCLI 0.12
- RVSN 0.05
- MACD
- BCLI 0.01
- RVSN 0.02
- Stochastic Oscillator
- BCLI 36.36
- RVSN 82.69
About BCLI Brainstorm Cell Therapeutics Inc.
Brainstorm Cell Therapeutics Inc is a biotechnology company. The company is developing novel adult stem cell therapies for debilitating neurodegenerative disorders such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Progressive Multiple Sclerosis (PMS), and Parkinson's disease (PD). Brainstorm's NurOwn, its proprietary process for the propagation of Mesenchymal Stem Cells (MSC) and differentiation into neurotrophic factor-(NTF) secreting cells (MSC-NTF), and their transplantation at, or near, the site of damage, offers the hope of more effectively treating neurodegenerative diseases.
About RVSN Rail Vision Ltd.
Rail Vision Ltd is a development-stage technology company that is engaged in the design, development, and assembly of railway detection systems designed to solve the challenges in railway operational safety, efficiency, and predictive maintenance. Its railway detection systems include different types of cameras, including optics, visible light spectrum cameras (video), and thermal cameras that transmit data to a ruggedized onboard computer which is designed to be suitable for the rough environment of a train's locomotive. It has developed its railway detection and systems to save lives, increase efficiency, and dramatically reduce expenses for the railway operator.